为奥地利医院药剂师制定和验证国家临床药学能力框架:一项多方法研究
J T Stoll1, B Böhmdorfer-McNair2,3, M Jeske4
1Department of Clinical Pharmacy, Innsbruck University, Innrain 15, 6020, Innsbruck, Austria. jasmin.stoll@uibk.ac.at.
International journal of clinical pharmacy
|August 7, 2024
概括
奥地利现在有一个国家医院药房能力框架,旨在支持劳动力发展. 该框架确保临床技能与欧洲标准保持一致,有助于未来的实施战略.
科学领域:
- 药房实践 在药房实践中
- 医疗保健劳动力发展工作人员
- 能力框架 能力框架
背景情况:
- 欧洲医院药学能力框架存在,但缺乏普遍采用.
- 国家适应对于有效实施和劳动力发展至关重要.
研究的目的:
- 为奥地利制定和验证国家医院药学能力框架.
- 支持奥地利医院药房工作人员的专业发展.
主要方法:
- 采用了三个阶段的多方法方法.
- 对现有框架和指导方针进行系统的文献审查.
- 专家小组对国家适当性框架草案的验证.
主要成果:
- 从28份文件中确定了379个行为能力.
- 将19个能力映射到欧洲共同培训框架 (CTF) 的"患者护理和临床药房技能"领域.
- 专家小组完善了奥地利背景的框架.
结论:
- 成功开发和验证了奥地利第一个国家临床药学能力框架.
- 强调需要对实施结构进行未来研究.
相关概念视频
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
54
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
54
Analysis of Population Pharmacokinetic Data
244
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
244
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
66
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
66
Accountability and Responsibility of a Nurse I
1.8K
Accountability in nursing is a fundamental principle that underscores the obligation of nurses to take responsibility for their actions and answer for any errors or omissions in patient care. This principle is grounded in the professional, legal, and ethical frameworks that shape nursing practice. For instance, nurses must adhere to all relevant laws, regulations, and practice standards, including guidelines set forth by nursing boards and professional bodies, to ensure their actions comply...
1.8K
Model Approaches for Pharmacokinetic Data: Compartment Models
85
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
85


